-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Genting Xinyao (01952.HK) issued an announcement. Weisipin® (arginine etramide tablets) and Yika® (injectable eracycline hydrochloride) passed the national health insurance negotiations and were included in the new edition of the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2026)” (new version of the National Medical Insurance Drug Catalogue). This health insurance admission will further enhance the accessibility and affordability of Weisipin® and Iga®, giving more patients the opportunity to benefit from innovative treatments. The new version of the National Medical Insurance Drug List will officially take effect on January 1, 2027. Meanwhile, Nafucang® (budesonide enteric capsules) continues to remain on the national medical insurance drug list.
Share
Listen to the news
Zhitong Finance App News, Genting Xinyao (01952.HK) issued an announcement. Weisipin® (arginine etramide tablets) and Yika® (injectable eracycline hydrochloride) passed the national health insurance negotiations and were included in the new edition of the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2026)” (new version of the National Medical Insurance Drug Catalogue). This health insurance admission will further enhance the accessibility and affordability of Weisipin® and Iga®, giving more patients the opportunity to benefit from innovative treatments. The new version of the National Medical Insurance Drug List will officially take effect on January 1, 2027. Meanwhile, Nafucang® (budesonide enteric capsules) continues to remain on the national medical insurance drug list.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending